Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss
Unless the price of ZEC rallies, Cypherpunk Technologies says it will need to raise a lot of money to pay for its upcoming FDA trials.
Bitcoin24h
$62,825.85-0.50%
Ethereum24h
$1,872.31-0.31%
BNB24h
$605.49-0.46%
XRP24h
$0.9992-0.70%
Solana24h
$74.96-1.05%
TRON24h
$0.3325-0.17%
Hyperliquid24h
$55.55-3.74%
Dogecoin24h
$0.0697-0.25%
UNUS SED LEO24h
$9.23-2.73%
Zcash24h
$486.66+0.58%
Nasdaq arthritis company holding Moshe Hogeg crypto hits all-time low
ZachXBT traced Enlivex’s RAIN token to Moshe Hogeg’s failed projects, and the Nasdaq-listed stock holding those tokens keeps hitting new lows.
Strategy’s BTC Yield turns negative for first time in years
The BTC Yield of MSTR stock in Michael Saylor’s treasury company, Strategy, has turned negative this quarter for the first time in years.
-
Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss—by Protos Staff
-
SpaceX crashed too hard for insiders’ bonus unlock—by Protos Staff
-
Is a crisis brewing at Crypto.com?—by Protos Staff
-
BitMart founder denies exit scam as withdrawals stall—by Protos Staff
-
Is Justin Sun mixing HTX’s reserves with Poloniex?—by Protos Staff
-
Jefferies slashes SanDisk price target 42% despite record earnings—by Protos Staff
-
Short-seller called Nvidia top by not trusting Jensen Huang—by Protos Staff
-
Did Bitcoin bridge Boltz silently warn of a government takeover?—by Protos Staff
-
Disgraced FTX claims broker is now soliciting Coldcard victims—by Protos Staff
